BNET Industries
Last Fiscal Year Sales:$35.9B
- Public
- DE
Dow Jones Description
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and improved earning power. We already successfully reorganized the Bayer Group and further streamlined our portfolio to create a new Bayer that is focused on its corporate strengths, its customers and the markets of the future. To help us achieve this goal, we then carried out a strategic realignment in order to concentrate in future on three high-potential, agile subgroups with largely independent operations: HealthCare, CropScience and MaterialScience, supported by three service companies. Our operating companies give us the access we need to the growth markets of the future. As an inventor company, we plan to continue setting trends in research-intensive areas. Innovations are the foundation for our competitiveness and our corporate growth, and thus for our success in the future. We believe our technical and commercial expertise entails a duty to contribute to sustainable development ? a principle we wholeheartedly endorse, mindful of its social, ethical and environmental elements. In awareness of our responsibilities as a corporate citizen, we define economy, ecology and social commitment as objectives of equal rank. We seek to retain society?s confidence through performance, flexibility and open communication as we work in pursuit of our overriding corporate goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.
Director, Finance
Klaus KuhnNumber of Employees 122,100
Peer Companies
NAICS Code Plastics Material and Resin Manufacturing: 325211
Recent Events
-
Bayers Betaferon approved in China for Treatment of Multiple Sclerosis
-
UPDATE 3-US FDA declines to approve Endo testosterone drug
-
UPDATE 1-Futuragene signs licence deal with Bayer CropScience
-
Bayer and United Nations Environment Programme Launch 19th Annual International Children's...
-
Bayer Consumer Care Launches CitracalR Calcium Plus Heart Health
-
German drug, chemical company Bayer's Q3 net income falls 10 per cent
-
Bayer, US Onyx launch phase III trial of Nexavar in patients with non-responsive thyroid cancer
-
BRIEF-Credit Suisse raises targets on European pharma cos
-
Bayer accused of hiding Yaz contraceptive risk
-
Bayer downgraded to neutral from buy at UBS
-
Abbott Laboratories to acquire Solvay Pharmaceuticals
-
Bayer's contested kidney cancer drug shows benefit
-
Bayer names new CEO
-
Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play...
-
Bayer's next CEO has a year to prepare Today
News & Analysis
Filter by
bayer ag and strategy - All News and Analysis
Bayer's Translation of Swiss Study of Yaz Blood Clot Risks Is Not Complete
BNET
- 2009-10-23
Bayer says that a study by Swissmedica, the Swiss medical authority, has shown that the risk of potentially fatal venous thromboembolisms is about the same for its Yaz contraceptive as it is with other pills. The results of the Swissmedic study have been eagerly anticipated by lawyers who have brought...
Bayer Hires The Hills' Lo Bosworth to Tout Birth Control Pill Yaz
BNET
- 2009-01-26
Bayer has hired Lo Bosworth, the least-interesting of the cast of MTV's The Hills, as an endorser and spokeswoman for birth-control pill Yaz. Bosworth, is regarded to have been brought onto the vapid show for the purpose of creating a rift between stars Lauren Conrad and Heidi...
Bayer Sells Dog Tags for Diabetics
BNET
- 2008-12-16
Bayer Diabetes Care is selling dog tags for youngsters with Type 1 diabetes. The tags are being sold as a trendy consciousness-raising item (even though the original meaning of "dog tag" was an ID necklace worn so that dead soldiers' corpses could be identified, and life expectancy for type 1...
Bayer's Trasylol Killed Too Many People; Lawsuits Arrive
BNET
- 2008-12-03
On the same day that news of a study of 49 randomized trials of Bayer's anti-bleeding drug Trasylol showed there was a higher risk of death than for alternative drugs, Bayer learned it was slapped with a lawsuit from a woman alleging her husband died because Trasylol was used in...
MEDRAD Adds Multi Vendor Service to ISO 13485:2003 Certification
- 2008-06-24
MEDRAD, INC., announced today that its Multi Vendor Service was added to MEDRAD's ISO 13485:2003 certification, making it one of only two major providers of ultrasound transducer and MRI coil repair services with the certification. Multi Vendor Service achieved this new certification by demonstrating to the International Organization for...
Pfizer, Novartis, Wyeth, GSK, Bayer to Discuss Latest Tactics and Strategies to Improve Patient Compliance and Communication.
- 2008-01-11
LONDON, January 11 /PRNewswire/ -- eyeforpharma, the global source of information and education for the pharmaceutical industry, announced today that the 5th annual Patient Compliance & Communication conference, London, 11-12 June 2008 has se LONDON, January 11 /PRNewswire/ -- ...
Bayer Schering Pharma Updated Company Profile: Outlook, Strategy and Forecasts
- 2008-01-08
NEW YORK -- Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.
Commencement 2007: Graduate Develops "Growable" Solution to Energy Issues.
- 2007-05-07
M2 PRESSWIRE-7 May 2007-Rensselaer Polytechnic Institute: Commencement 2007: Graduate Develops "Growable" Solution to Energy IssuesC1994-2007 M2 COMMUNICATIONS LTD RDATE:04052007 Troy, N.Y. -- Sky-rocketing oil prices, rising demand for reliance on renewable resources, and an increase in environmental consciousness have placed...
9,700 miles traveled — on a bicycle
- 2006-10-20
Peter Hoogenboom woke up Thursday morning in Lehi, just a few minutes south of his home in Salt Lake City if he were traveling by car. He hasn't seen home since March 18, when he pedaled away for a 48- state, 9,700-mile bike ride, with his wife Pat...
EU seeks assurance on traces of unauthorized GM-rice in US
- 2006-08-21
BRUSSELS AFP — The European Commission said it had asked the US for information about unauthorized genetically modified rice found in the United States to determine if it posed a risk in Europe. US authorities had said on Friday that Bayer CropScience, the agro-industry arm of the German chemicals...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Klaus Kuhn | Director, Finance |
| Richard Pott | Director, Strategy and Human Resources |
| Wolfgang Plischke | Director, Innovation, Technology and Environment |
| Hartmut Klusik | Head, Product Supply |
| Gary S Balkema | Executive Committee Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Arthur J Higgins | Chairman, HealthCare |
| Werner Wenning | Executive Chairman |
| Klaus Kleinfeld | Board of Directors |
| Paul Achleitner | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Finance | Current |
| University of South Carolina | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Strategy and Human Resources | Current |
| University of Cologne | doctorate in physics | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Innovation, Technology and Environment | Current |
| Bayer HealthCare AG | Manager | Current |
| Bayer HealthCare AG | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Head, Product Supply | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Chairman, HealthCare | Current |
| Enzon Pharmaceuticals, Inc. | CEO | Former |
| Pharmaceutical Research and Manufacturers of America | member | Former |
| Bayer HealthCare, Animal Health Division | Chairman | Former |
| Enzon Pharmaceuticals, Inc. | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Chairman | Current |
| Henkel AG & Co. KGaA | Supervisory Board | Current |
Klaus Kleinfeld is president and chief executive officer of Alcoa. He joined the company in 2007 as president and chief operating officer and seven months later assumed CEO responsibilities. He has served on Alcoa's board of directors since 2003. Alcoa is a world leader in the production and management of a very sustainable product: aluminum. Nearly 75% of the aluminum ever produced since 1888 is still in use today. The company has been a technology leader since its beginning, providing more than 90% of the aluminum alloys used in aircraft and space flight; helping making automobiles lighter, without compromising safety or performance; manufacturing sheet that created the ultimate recyclable container, the aluminum beverage can; and providing building and construction industry materials that help further the green building movement. In addition, to serving customers in these markets, Alcoa also markets wheels, fastening systems, precision and investment castings, and building systems. The company has 97,000 employees in 34 countries. Before coming to Alcoa, Mr. Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as chief executive officer of Siemens AG starting in 2005. During his tenure, Mr. Kleinfeld presided over a dramatic transformation of the company, reshaping the company's portfolio around three high growth areas, resulting in increase of revenues and market capitalization nearly doubled. Prior to his service on the Managing Board of Siemens AG, Mr. Kleinfeld was President and Chief Executive Officer of Siemens Corporation, its U.S. arm and the company's largest region. In addition to serving on Alcoa's board, he is a member of the board of Bayer AG. On the personal front, Mr. Kleinfeld was born in Bremen, Germany and educated at the University of Goettingen and University of Wuerzburg, both in Germany. He holds a Ph.D in strategic management and master's degree in business administration. In his leisure time, he enjoys skiing, tennis, the arts and is a marathon runner. Mr. Kleinfeld resides in New York with his wife and children.
| Organization | Position | Status |
|---|---|---|
| Alcoa, Inc. | President & Chief Executive Officer | Current |
| Bayer AG | Board of Directors | Current |
| Alcoa, Inc. | Board of Directors | Current |
| Siemens AG | President & CEO | Former |
| Siemens Corporation | Chief Executive Officer | Former |
| Alcoa, Inc. | Chief Operating Officer | Former |
| Siemens Corporation | Chief Operating Officer | Former |
| Siemens AG | Chief Operations Officer, U.S. | Former |
| Siemens AG | Executive Vice President | Former |
| Siemens AG | Audit Committee Principal | Former |
| Citigroup Inc. | Board of Directors | Former |
| Siemens AG | Board of Directors | Former |
| Siemens Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Allianz SE | Executive Director, Finance | Current |
| Bayer AG | Board of Directors | Current |
| Goldman, Sachs & Co. | Vice President, Mergers & Acquisitions | Former |
| Bain & Company | Manager, Strategy Consulting | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Committee Member | Current |
| Bayer HealthCare, Animal Health Division | President, Worldwide Bayer Consumer Care Division | Former |
| Fairleigh Dickinson University | master of business administration degree | Former |
Executive News
-
Report from Europe: U.S. Close vs. China Rebound
-
Alcoa Named Component of Dow Jones Sustainability Index for Eighth Consecutive Year
-
Alcoa says global aluminium demand to fall 5.5 pct -Bloomberg
-
Siemens To Settle Bribery Charges with Three Former Execs
-
Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
Bayer AG (BAY.F) May Be Ready for Deals After Lost Intervet Bid
-
Inventories May Temper Aluminum Rally
Industry Transcripts by Seeking Alpha
-
Oil-Dri Corporation of America F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about ODC
-
AeroVironment Inc. F2Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about AVAV
-
NCI Building Systems, Inc. F4Q09 (Qtr End 11/01/09) Earnings Call Transcript
on Dec 08, 2009about NCS
-
Toro Company F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Dec 08, 2009about TTC
-
KMG Chemicals F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 07, 2009about KMGB
Glass Door
Bayer AG
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- Flat World Knowledge: A Disruptive Business Model 6 votes
Presented by American Express